Clinical Trials Logo

Retroviridae Infections clinical trials

View clinical trials related to Retroviridae Infections.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04983030 Recruiting - HIV Clinical Trials

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Start date: April 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

A multicenter, randomized, parallel-group, placebo-controlled, double-blind, Phase 1/2a clinical study to investigate the safety, tolerability, immunogenicity and exploratory efficacy of a vaccine regimen consisting of an Ad26.Mos4.HIV prime and a boost with Modified Vaccinia Ankara (MVA)-BN-HIV in combination with broadly neutralizing antibodies (bNAb) PGT121, PGDM1400, and VRC07-523LS in human immunodeficiency virus type 1 (HIV-1)-infected study participants on suppressive anti-retroviral therapy (ART).

NCT ID: NCT01492036 Recruiting - Cancer Clinical Trials

Long-Term Follow-Up of Recipient of Gene Transfer Research

Start date: December 9, 2011
Phase:
Study type: Observational

The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about patients who have received gene transfer therapy, in order for researchers to track and review the long-term safety and any effects (good or bad) of gene transfer therapy.